DK108495C - Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof. - Google Patents

Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof.

Info

Publication number
DK108495C
DK108495C DK626764A DK626764A DK108495C DK 108495 C DK108495 C DK 108495C DK 626764 A DK626764 A DK 626764A DK 626764 A DK626764 A DK 626764A DK 108495 C DK108495 C DK 108495C
Authority
DK
Denmark
Prior art keywords
benzomorphans
substituted
preparation
acid addition
addition salts
Prior art date
Application number
DK626764A
Other languages
Danish (da)
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Application granted granted Critical
Publication of DK108495C publication Critical patent/DK108495C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Discharge Lamp (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK626764A 1963-12-20 1964-12-19 Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof. DK108495C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33229663A 1963-12-20 1963-12-20

Publications (1)

Publication Number Publication Date
DK108495C true DK108495C (en) 1967-12-27

Family

ID=23297612

Family Applications (4)

Application Number Title Priority Date Filing Date
DK429865A DK108497C (en) 1963-12-20 1964-12-19 Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof.
DK626864A DK106552C (en) 1963-12-20 1964-12-19 Process for the preparation of substituted 6,7-benzomorphans.
DK429765A DK108496C (en) 1963-12-20 1964-12-19 Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof.
DK626764A DK108495C (en) 1963-12-20 1964-12-19 Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
DK429865A DK108497C (en) 1963-12-20 1964-12-19 Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof.
DK626864A DK106552C (en) 1963-12-20 1964-12-19 Process for the preparation of substituted 6,7-benzomorphans.
DK429765A DK108496C (en) 1963-12-20 1964-12-19 Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof.

Country Status (12)

Country Link
AT (4) AT249277B (en)
BE (2) BE657405A (en)
CH (7) CH449643A (en)
DE (2) DE1445853A1 (en)
DK (4) DK108497C (en)
ES (4) ES307300A1 (en)
FR (2) FR4345M (en)
GB (2) GB1077711A (en)
IL (2) IL22642A (en)
NL (3) NL6414820A (en)
NO (2) NO119273B (en)
SE (2) SE322779B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
EP2987788A1 (en) 2002-05-17 2016-02-24 Taiwanj Pharmaceuticals Co., Ltd. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
JP5486928B2 (en) 2007-02-26 2014-05-07 ヴァイティー ファーマシューティカルズ,インコーポレイテッド Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
JP5451611B2 (en) 2007-07-26 2014-03-26 ヴァイティー ファーマシューティカルズ,インコーポレイテッド Cyclic inhibitor of 11β-hydroxysteroid dehydrogenase 1
AR069207A1 (en) 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc CYCLIC UREAS AS INHIBITORS OF THE 11 BETA - HIDROXI-ESTEROIDE DESHIDROGENASA 1
CA2704628C (en) 2007-11-16 2016-11-29 Boehringer Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
WO2009075835A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceutical, Inc CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
JP5490020B2 (en) 2008-01-24 2014-05-14 ヴァイティー ファーマシューティカルズ,インコーポレイテッド Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1
JP5734666B2 (en) 2008-02-11 2015-06-17 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 1,3-oxaazepan-2-one and 1,3-diazepan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase 1
US20110028445A1 (en) * 2008-02-12 2011-02-03 Boehringer Ingelheim International Gmbh Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
US8598160B2 (en) 2008-02-15 2013-12-03 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
JP5538365B2 (en) 2008-05-01 2014-07-02 ヴァイティー ファーマシューティカルズ,インコーポレイテッド Cyclic inhibitor of 11β-hydroxysteroid dehydrogenase 1
US8242111B2 (en) 2008-05-01 2012-08-14 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
CL2009001058A1 (en) 2008-05-01 2010-09-10 Vitae Pharmaceuticals Inc Compounds derived from substituted oxazines, inhibitors of 11b-hydroxysteroid dehydrogenase type-1; pharmaceutical composition; and use of the compound to inhibit the activity of 11b-hsd1, as in the treatment of diabetes, dyslipidemia, hypertension, obesity, cancer, glaucoma, among others.
PL2300461T3 (en) 2008-05-01 2013-09-30 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8765780B2 (en) 2008-05-13 2014-07-01 Boehringer Ingelheim International Gmbh Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
CA2729998A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2687525B1 (en) 2008-07-25 2015-09-23 Boehringer Ingelheim International GmbH Cyclic inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
WO2010046445A2 (en) 2008-10-23 2010-04-29 Boehringer Ingelheim International Gmbh Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
WO2010089303A1 (en) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
UA109255C2 (en) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2010139673A1 (en) 2009-06-02 2010-12-09 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
EP2448928B1 (en) 2009-07-01 2014-08-13 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
AR078887A1 (en) 2009-11-06 2011-12-07 Boehringer Ingelheim Int ARILO AND HETEROARILCARBONILO DERIVATIVES OF HEXAHYDROINDENOPIRIDINE AND OCTAHYDROBENZOQUINOLINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
JP5860042B2 (en) 2010-06-16 2016-02-16 ヴァイティー ファーマシューティカルズ,インコーポレイテッド Substituted 5, 6 and 7 membered heterocycles, medicaments containing such compounds and their use
WO2011161128A1 (en) 2010-06-25 2011-12-29 Boehringer Ingelheim International Gmbh Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
WO2012059416A1 (en) 2010-11-02 2012-05-10 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders
TWI537258B (en) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
JP2014524438A (en) 2011-08-17 2014-09-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Indenopyridine derivatives

Also Published As

Publication number Publication date
DE1445854A1 (en) 1968-12-05
AT249277B (en) 1966-09-12
ES307301A1 (en) 1965-05-16
GB1092394A (en) 1967-11-22
CH448118A (en) 1967-12-15
NL6414820A (en) 1965-06-21
DK108496C (en) 1967-12-27
ES307302A1 (en) 1965-05-16
DK108497C (en) 1967-12-27
CH449640A (en) 1968-01-15
SE305657B (en) 1968-11-04
AT253687B (en) 1967-04-25
GB1077711A (en) 1967-08-02
NO119274B (en) 1970-04-27
ES307299A1 (en) 1965-05-16
DK106552C (en) 1967-02-20
SE322779B (en) 1970-04-20
BE657405A (en) 1965-06-21
IL22643A (en) 1968-07-25
IL22642A (en) 1968-07-25
AT249276B (en) 1966-09-12
NO119273B (en) 1970-04-27
NL127995C (en)
BE657406A (en) 1965-06-21
NL6414821A (en) 1965-06-21
CH449639A (en) 1968-01-15
FR4345M (en) 1966-08-16
CH449642A (en) 1968-01-15
DE1445853A1 (en) 1968-12-05
CH449643A (en) 1968-01-15
FR4346M (en) 1966-08-16
CH449641A (en) 1968-01-15
AT261126B (en) 1968-04-10
CH446371A (en) 1967-11-15
ES307300A1 (en) 1965-05-01

Similar Documents

Publication Publication Date Title
DK108496C (en) Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof.
DK108972C (en) Process for the preparation of lipoylpyridoxamine or acid addition salts thereof.
DK125421B (en) Analogous process for the preparation of 5-substituted-aza-dibenzo-cycloheptenes or acid addition salts thereof.
DK106797C (en) Process for the preparation of 3-hydroxy-5-aminomethyl-isoxazole or acid addition salts thereof.
DK116000B (en) Process for the preparation of amino-halo-benzylamines or acid addition salts thereof.
DK117000B (en) Process for the preparation of substituted phenylamino-1,3-diazacyclopentenes (2) or acid addition salts thereof.
DK115851B (en) Process for the preparation of 1,2-dihydro-4-aryl-quinazolines or acid addition salts thereof.
DK112872B (en) Process for the preparation of [1,2-α] -imidazopyridines or acid addition salts thereof.
DK107942C (en) Process for the preparation of 1,5-disubstituted 3-aza-1-pentanols or acid addition salts thereof.
DK108394C (en) Process for the preparation of substituted imidazo- or pyrimido-quinazolines or acid addition salts thereof.
DK125552B (en) Process for the preparation of 1,2,3,4-tetrahydroisoquinoline-2-carboxamidines or acid addition salts thereof.
DK121604B (en) Process for the preparation of substituted iminocycloheptatriene derivatives or acid addition salts thereof.
DK106381C (en) Process for the preparation of 2-dimethylamino-3,5,6-trimethylpyrazine or acid addition salts thereof.
DK112449B (en) Process for the preparation of 2,3-dihydro-5-pyridyl-1H-1,4-benzodiazepines or acid addition salts thereof.
DK111893B (en) Process for the preparation of substituted methylhydrazines or acid addition salts thereof.
DK105649C (en) Process for the preparation of 2-dimethylaminopyrazine or acid addition salts thereof.
DK106092C (en) Process for the preparation of basic substituted 11-alkyl-5,6-dihydro-6-oxo-morphanthridines or acid addition salts thereof.
DK118667B (en) Process for the preparation of 1,3,4,5-tetrahydro-5-phenyl-2H-1,4-benzodiazepin-2-ones or acid addition salts thereof.
DK118345B (en) Process for the preparation of 2,5-diacylamino-3,6-diamino-1,4-dihydroxybenzenes or acid addition salts thereof.
DK106144C (en) Process for the preparation of aryl-N- (1,2,5,6-tetrahydro-1,3-dialkyl-4-pyridyl) -alkanoylamides or acid addition salts thereof.
DK107170C (en) Process for the preparation of 10-monoalkylaminoalkyl-10,11-dihydro-11-oxo-5H-dibenzo (b, e) (1,4) diazepines or acid addition salts thereof.
DK108857C (en) Process for the preparation of phenylcyclohexylalkylamines or acid addition salts thereof.
DK112530B (en) Process for the preparation of α-phenyl-β-tetrahydofuryl-2-propionitriles or acid addition salts thereof.
DK118241B (en) Process for the preparation of 2-amino-oxazolines or acid addition salts thereof.
DK106911C (en) Process for the preparation of 2,3-dihydro-5-aryl-1H-1,4-benzodiazepine derivatives or acid addition salts thereof.